Global X Management Company’s Kite Pharma, Inc. KITE Stock Holding History

Global X Management Company’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-734	Closed	-$132K	–	1109
2017 Q3	$132K	Buy	734 +72	+11%	+$10K	﹤0.01%	845
2017 Q2	$69K	Buy	662 +104	+19%	+$8.49K	﹤0.01%	944
2017 Q1	$44K	Buy	558 +465	+500%	+$28.8K	﹤0.01%	943
2016 Q4	$4K	Buy	93 +3	+3%	+$147	﹤0.01%	1078
2016 Q3	$5K	Hold	90	–	–	﹤0.01%	1073
2016 Q2	$5K	Buy	+90	New	+$4.42K	﹤0.01%	941

Global X Management Company's KITE Position: Q4 2017 in Review

Global X Management Company sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 734 shares — an estimated $132K sold.

Global X Management Company first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $132K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Global X Management Company reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Global X Management Company sold 734 Kite Pharma, Inc. shares in Q4 2017, an estimated $132K.
Global X Management Company first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
Global X Management Company's Kite Pharma, Inc. position peaked at $132K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Global X Management Company's 13F filing for Q4 2017, filed 8 Feb 2018.